Physician profile
Jonathan Carlson
NPI 1922219500
$20,009.04
in general payments reported to CMS, 2019-2025
20 companies · $1,727 in 2025
The $1,727 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,547 · 2020: $2,816 · 2021: $4,526 · 2022: $2,640 · 2023: $1,554 · 2024: $1,198 · 2025: $1,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,452 · Travel and Lodging: $27.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,451.90 |
| Travel and Lodging | $27.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $7,904.89 | 2019-2020 | |
| Abbott Laboratories | $3,834.87 | 2020-2025 | Proclaim, Eterna |
| Medtronic, INC. | $3,663.70 | 2021-2025 | Percept Pc Brainsense |
| Boston Scientific Corporation | $1,504.62 | 2019-2025 | Bionic Navigator, Vercise, Vigilant X4 Crt-D |
| Painteq LLC | $772.94 | 2021-2022 | |
| Spinal Simplicity, LLC | $714.69 | 2022 | |
| Bioventus LLC | $318.27 | 2022-2023 | Stimrouter Implantable Kit |
| Globus Medical, INC. | $293.08 | 2022-2023 | Excelsiusgps Robotic Navigation System, Sable |
| Stryker Corporation | $190.80 | 2021-2025 | Mild Device Kit, Optablate |
| Biotronik Nro, INC. | $155.55 | 2025 | Prospera |
| Relievant Medsystems, INC. | $136.13 | 2022 | |
| Neurocrine Biosciences, INC. | $120.27 | 2021 | |
| Nevro Corp. | $100.32 | 2022-2023 | Senza |
| Depuy Synthes Sales INC. | $84.78 | 2019 | |
| Stimwave Technologies Incorporated | $62.05 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $55.08 | 2022 | |
| Abbvie INC. | $29.58 | 2024 | |
| Kyowa Kirin, INC. | $27.36 | 2021 | |
| Avanos Medical | $21.77 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $18.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.